Your browser doesn't support javascript.
loading
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.
Yamamoto, Ryusuke; Hiramoto, Nobuhiro; Fujimoto, Ayumi; Yamazaki, Hirohito; Mori, Takehiko; Uchida, Naoyuki; Doki, Noriko; Kato, Jun; Nishikubo, Masashi; Kako, Shinichi; Nishida, Tetsuya; Ota, Shuichi; Onizuka, Makoto; Eto, Tetsuya; Onodera, Koichi; Ikegame, Kazuhiro; Matsuoka, Ken-Ichi; Kanda, Yoshinobu; Fukuda, Takahiro; Atsuta, Yoshiko; Onishi, Yasushi.
Afiliación
  • Yamamoto R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. kvlqt1789@gmail.com.
  • Fujimoto A; Department of Hematology, Shimane University Hospital, Izumo, Japan.
  • Yamazaki H; Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan.
  • Mori T; Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kato J; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Onodera K; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Ikegame K; Department of Hematology, Hyogo Medical University Hospital, Hyogo, Japan.
  • Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
  • Onishi Y; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Bone Marrow Transplant ; 59(5): 688-691, 2024 May.
Article en En | MEDLINE | ID: mdl-38341498

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Anemia Aplásica / Trastornos Linfoproliferativos / Suero Antilinfocítico Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Anemia Aplásica / Trastornos Linfoproliferativos / Suero Antilinfocítico Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Japón